BNTX
BioNTech SE · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -25.0% ·
share flow -5.1% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 760.71K | $74.78M | n/a | −1 |
| Q2 2026 | 92 | 0 | 32.20M | $3.00B | +8 | −10 |
| Q1 2026 | 95 | +4 | 29.16M | $2.59B | +13 | −9 |
| Q4 2025 | 91 | +4 | 29.39M | $2.80B | +4 | n/a |
| Q3 2025 | 13 | +1 | 23.37M | $2.30B | +1 | n/a |
| Q2 2025 | 9 | -3 | 22.65M | $2.41B | +1 | −4 |
| Q1 2025 | 10 | -2 | 14.39M | $1.31B | n/a | −2 |
| Q4 2024 | 12 | -1 | 14.53M | $1.66B | +1 | −2 |
| Q3 2024 | 12 | +1 | 13.93M | $1.65B | +3 | −2 |
| Q2 2024 | 11 | n/a | 15.47M | $1.24B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.16M | n/a | $868.69M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | Baillie Gifford ✦ | 8.04M | -1.5% | $855.90M | 0.6% | ▼ Trim | 5 | SEC ↗ ×5 |
| 3 | PRIMECAP Management ✦ | 4.00M | -1.1% | $426.04M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 1.31M | n/a | $139.90M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 5 | Dodge & Cox ✦ | 877.44K | New | $93.42M | 0.1% | New | 1 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passive) | 145.31K | -5.0% | $15.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 103.75K | +2.4% | $11.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Marshall Wace ✦ | 4.84K | -98.1% | $518,917 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.71K | -98.8% | $288,747 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Dodge & Cox | $93.42M | 0.1% |
Exited
| Viking Global Investors | $80.13M | was 0.3% |
| Millennium Management | $49.62M | was 0.1% |
| D. E. Shaw & Co. | $1.54M | was 0.0% |
| Bridgewater Associates | $1.30M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 272 holders, 47.28M shares, $3.59B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, 10% owner · 36.21K sh · $3.45M
Officer, 10% owner · 27.00K sh · $2.49M
Officer, 10% owner · 24.00K sh · $2.30M
Officer, 10% owner · 21.00K sh · $2.03M
Officer, 10% owner · 72.00K sh · $7.00M
Officer, 10% owner · 17.00K sh · $1.64M
Officer, 10% owner · 17.00K sh · $1.66M
Officer, 10% owner · 32.00K sh · $3.14M
Officer, 10% owner · 34.00K sh · $3.34M
Officer, 10% owner · 34.00K sh · $3.35M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology